Cystic fibrosis: a model system for precision medicine. - Wikidata - awgldk - TriplyDB

Cystic fibrosis: a model system for precision medicine.

Cystic fibrosis: a model system for precision medicine.

http://www.wikidata.org/entity/Q37097931

about

Cystic fibrosis lung environment and Pseudomonas aeruginosa infection.Highlights from the 2016 North American Cystic Fibrosis Conference.Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?Measure for Measure: Biomarker standards and transparency.Personalized or Precision Medicine? The Example of Cystic Fibrosis Lumacaftor/ivacaftor, a novel agent for the treatment of cystic fibrosis patients who are homozygous for the F580del CFTR mutation.Gap Junctions Are Involved in the Rescue of CFTR-Dependent Chloride Efflux by Amniotic Mesenchymal Stem Cells in Coculture with Cystic Fibrosis CFBE41o- Cells.Innovative Therapeutic Strategies for Cystic Fibrosis: Moving Forward to CRISPR Technique.Precision Medicine In Action: The Impact Of Ivacaftor On Cystic Fibrosis-Related Hospitalizations.

P2860

Q36213685-25E316B3-5A8F-4248-BEF7-9267B255C288 Q38684319-B30B54AA-D04C-4077-9584-42D9A47EF050 Q38819976-EFE06D89-168E-409A-8AA9-E911246926BF Q38866177-E0F94F8D-8A79-4A01-A4A8-C8AA323DF259 Q39414218-19008EBA-D9FF-4874-8D63-04B176F358EB Q47824569-6EE70F5D-D527-45B8-A8C5-3C3897C3A36C Q51741037-223CAD11-CAB2-41F6-91EC-C4BAF9489ACB Q55090892-83ABEBF9-EB0F-4063-B898-F2877D7769C6 Q55517629-1E702504-4C7C-420A-8C2A-1E209F1E797E

P2860

Cystic fibrosis: a model system for precision medicine.

http://www.wikidata.org/entity/Q37097931

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 March 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cystic fibrosis: a model system for precision medicine.

@en

Cystic fibrosis: a model system for precision medicine.

@nl

type

label

Cystic fibrosis: a model system for precision medicine.

@en

Cystic fibrosis: a model system for precision medicine.

@nl

prefLabel

Cystic fibrosis: a model system for precision medicine.

@en

Cystic fibrosis: a model system for precision medicine.

@nl

P1433

Q37097931-CEE7E1E9-38A1-43A3-84A7-257CFE144586

P1476

Q37097931-0C66D2BF-2067-4387-8E84-25C85D4433CE

P2093

Q37097931-6513BF80-4235-4965-9631-4BE7652EC51F

Q37097931-77A8276C-1CD0-4656-B4BD-31D13C733366

P2860

Q37097931-00E6E6D9-ACE1-4E91-98CC-59650E722A74

Q37097931-069B383B-8763-4A93-8B14-83305BD02A63

Q37097931-13D7F911-11BF-47DA-9476-867A89F410B4

Q37097931-161C49F2-8097-4FA2-8D1A-FAB46A11DB71

Q37097931-2B277D5A-EAA0-4575-9FC5-F35E4D22CCBF

Q37097931-2D04896C-FE26-4904-9C08-67BCBDB3CC4C

Q37097931-302A3168-0D06-4A8A-B5A6-136D21B8D3D6

Q37097931-31EB437C-1CF7-4F5E-8855-38C9E3D13BAD

Q37097931-3A35A932-7677-4DB6-985A-3A0A78CE2853

Q37097931-3E7731EA-58BF-4607-838F-6B3A3B877F38

P304

Q37097931-E256C5C2-3B21-4E15-AEBA-2404E9A356D8

P31

Q37097931-CF953189-C82C-473C-BE34-3712A6A6E234

P356

Q37097931-1BA0DF40-6CB8-4827-BC5F-A671DB1F3F03

P433

Q37097931-89794C7E-ED19-4B64-ADA0-29EB699293F4

P478

Q37097931-9BCF0282-C76E-4708-99C1-F19C92B31EC6

P50

Q37097931-70151A75-18A4-4FD4-953C-18D153D573F2

P577

Q37097931-83EB40BD-C06B-4A01-81A1-53A0E742B480

P698

Q37097931-55E269A0-8763-4813-81B4-2BA57C4F448E

P921

Q37097931-7F346C33-AB53-4986-AF47-B427DA27D385

P932

Q37097931-B3508C9F-1177-454F-AD44-7454BACF6684

P356

MOP.0000000000000351

P1433

Current Opinion in Pediatrics

P1476

Cystic fibrosis: a model system for precision medicine

@en

P2093

Scott D Sagel

http://www.w3.org/2001/XMLSchema#string

Stacey L Martiniano

http://www.w3.org/2001/XMLSchema#string

P2860

Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

A functional CFTR assay using primary cystic fibrosis intestinal organoids

Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients

Synthetic aminoglycosides efficiently suppress cystic fibrosis transmembrane conductance regulator nonsense mutations and are enhanced by ivacaftor

Genotype and phenotype in cystic fibrosis.

Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial.

Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation.

Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial.

Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy

P304

312-317

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MOP.0000000000000351

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Edith T Zemanick

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27031658

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

P932

4946574

http://www.w3.org/2001/XMLSchema#string